Incentives for Research, Development, and Innovation in Pharmaceuticals
Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement diffe - rent measures that promote research in these less profitable areas. The lack of incentives for...
Κύριος συγγραφέας: | |
---|---|
Συγγραφή απο Οργανισμό/Αρχή: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Madrid :
Springer Healthcare Iberica : Imprint: Springer Healthcare,
2011.
|
Σειρά: | Economía de la Salud y Gestión Sanitaria
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Introduction
- Incentives for innovation: a survey
- Incentives for innovation: neglected diseases
- When patents are not enough: supplementary incentives for pharmaceutical innovation
- The Contribution of the United States, Europe and Japan in Discovering New Drugs: 1982 2003
- The use of pay for performance for drugs: can it improve incentives for innovation?
- Drug Price Regulation: Recent Trends and Downstream Neglected Issues.